Your browser doesn't support javascript.
loading
Significance of ramucirumab following atezolizumab plus bevacizumab therapy for hepatocellular carcinoma using real-world data.
Shimose, Shigeo; Sugimoto, Rie; Hiraoka, Atsushi; Tanaka, Masatoshi; Iwamoto, Hideki; Tanaka, Yuki; Tada, Fujimasa; Ohama, Hideko; Niizeki, Takashi; Shirono, Tomotake; Moriyama, Etsuko; Noda, Yu; Kamachi, Naoki; Nakano, Masahito; Kuromatsu, Ryoko; Koga, Hironori; Kawaguchi, Takumi.
Afiliación
  • Shimose S; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
  • Sugimoto R; Department of Hepato-Biliary-Pancreatology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.
  • Hiraoka A; Gastroenterology Center, Ehime Prefectural Central Hospital, Matsuyama, Japan.
  • Tanaka M; Clinical Research Center, Yokokura Hospital, Miyama, Japan.
  • Iwamoto H; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
  • Tanaka Y; Department of Hepato-Biliary-Pancreatology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.
  • Tada F; Gastroenterology Center, Ehime Prefectural Central Hospital, Matsuyama, Japan.
  • Ohama H; Gastroenterology Center, Ehime Prefectural Central Hospital, Matsuyama, Japan.
  • Niizeki T; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
  • Shirono T; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
  • Moriyama E; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
  • Noda Y; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
  • Kamachi N; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
  • Nakano M; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
  • Kuromatsu R; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
  • Koga H; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
  • Kawaguchi T; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
Hepatol Res ; 53(2): 116-126, 2023 Feb.
Article en En | MEDLINE | ID: mdl-36316794

Texto completo: 1 Colección: 01-internacional Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Hepatol Res Año: 2023 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Colección: 01-internacional Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Hepatol Res Año: 2023 Tipo del documento: Article País de afiliación: Japón